Anadolu Medical Center
| Turcja | Austria | Hiszpania | |
| Nano-nóż | od $9,500 | od $25,000 | od $12,000 |
Państwo nie płacą za usługi Bookimed. Ceny na nano-nóż na stronie odpowiadają cennikowi kliniki. Płatność dokonywana jest bezpośrednio w klinice po przyjeździe. Dostępna jest płatność w ratach.
Bookimed dba o Państwa bezpieczeństwo. Współpracujemy tylko z klinikami spełniającymi wysokie międzynarodowe standardy w przeprowadzaniu nano-noża. Posiadają one wymagane licencje do obsługi pacjentów międzynarodowych na całym świecie.
Bookimed oferuje bezpłatną pomoc i wsparcie. Osobisty koordynator medyczny pozostaje w kontakcie przed, w trakcie i po podróży. Nie będą Państwo sami w innym kraju podczas procedury Nano-nóż.
Day 1 - Arrival
Day 2 - Pre-Operation
Day 3 - Pre-Operation
Day 4 - NanoKnife Procedure
Day 5 - Post-Operation
Week 1 - Rehabilitation
Week 2-4 - Rehabilitation
Week 5-6 - Rehabilitation
Please note that each patient"s recovery timeline may vary depending on their individual health condition, the size and location of the tumor, and their overall physical fitness. Always consult with your doctors and follow their advice for the best possible outcome.
Dr Solak specjalizuje się w leczeniu różnych nowotworów, w tym raka piersi, płuc i nowotworów przewodu pokarmowego, z rozległym doświadczeniem zdobytym w najlepszych instytucjach.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
Specjalizuje się w operacjach robotycznych i laparoskopowych, w tym w zaawansowanych procedurach, takich jak robotyczna radykalna prostatektomia i laparoskopowa sakrokolpopeksja w İstinye University Liv Hospital Topkapı.
Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.
MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.
Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.